Cited by 149Genomics and Rare DiseasesGenetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Prioritization of neurodevelopmental disease genes by discovery of new mutations

Open access
Hoischen, Alexander, Krumm, Niklas, Eichler, Evan E·2014·Nature Neuroscience

Abstract

Advances in genome sequencing technologies have begun to revolutionize neurogenetics, allowing the full spectrum of genetic variation to be better understood in relation to disease. Exome sequencing of hundreds to thousands of samples from patients with autism spectrum disorder, intellectual disability, epilepsy and schizophrenia provides strong evidence of the importance of de novo and gene-disruptive events. There are now several hundred new candidate genes and targeted resequencing technologies that allow screening of dozens of genes in tens of thousands of individuals with high specificity and sensitivity. The decision of which genes to pursue depends on many factors, including recurrence, previous evidence of overlap with pathogenic copy number variants, the position of the mutation in the protein, the mutational burden among healthy individuals and membership of the candidate gene in disease-implicated protein networks. We discuss these emerging criteria for gene prioritization and the potential impact on the field of neuroscience.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nn.3703

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several rare, highly penetrant mutations in evolutionarily constrained fetal brain-expressed genes are associated with ASD, schizophrenia, intellectual disability, and epilepsy.

    “Several rare, highly penetrant mutations in evolutionarily constrained fetal brain-expressed genes are associated with ASD, schizophrenia and intellectual disability, as well as epilepsy83,85–87.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [21]O’Roak BJ Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders Science 2012 338 1619 22 23160955 PMC3528801

Cited by

Sorted by citations

Authors
Hoischen, A., Krumm, N., & Eichler, E. E.
Affiliations
  • Radboud University Nijmegen (NL)
  • University of Washington (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
  • Hoischen, Alexander
  • Eichler, Evan E
Venue
Nature Neuroscience
Published
2014-05-27
Volume
17
Issue
6
Pages
764-772
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W2011747578
Cited by
149
References
94
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 14 · 2019: 16 · 2018: 19 · 2017: 18 · 2016: 20 · 2015: 21 · 2014: 8
FWCI
2.96
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • ZonMw
  • National Institutes of Health
  • National Institute of Mental Health (R01MH101221)
  • National Institute of General Medical Sciences (T32GM007266)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
Keywords
neurodevelopmental disorders, gene prioritization, de novo mutations, pathogenic variants, autism spectrum disorder, intellectual disability, epilepsy, schizophrenia, copy number variation, targeted sequencing, candidate genes, protein networks, mutational burden, exome sequencing
MeSH terms
Humans, Mutation, Nervous System Diseases, Genetic Predisposition to Disease, Genetic Association Studies, Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review